Longevity or Marketing? Dissecting the Claims of the Blueprint Protocol

American Council on Science and Health analysis (byline Mauro Proença, published 10 February 2025; byline and date confirmed on the fetched page) concluding Johnson's reported results are 'in reality, anecdotal evidence or, at best, a case study,' and that Blueprint 'also functions as an online store, selling numerous costly products that its creator... considers healthy despite lacking solid scientific evidence.' The article separately documents, from Johnson's own public statements and the Netflix Blueprint documentary, that Johnson discontinued young-plasma exchange after seeing no benefit, discontinued growth hormone after roughly 100 days due to side effects (increased intracranial pressure, headaches, elevated blood glucose), and abandoned rapamycin. Established science-advocacy expert source under the sourced-critique standard.